New anti-VEGF agents for wet age-related macular degeneration can extend injection intervals to 3-5 months but may increase inflammation risk, prompting calls for tailored treatment plans. Medscape Medical News
Five ways to make your ophthalmology practice more sustainable
AMELIA ISLAND, Fla. — Health care contributes significantly to global carbon emissions, so two clinicians speaking at the Women in Ophthalmology Summer Symposium shared five recommendations for reducing that footprint.Emily Schehlein, MD, a glaucoma an…
Ridge sign helps identify anterior, posterior planes in SMILE
A new sign in the armamentarium helps to confirm correct dissection of the anterior and posterior planes in SMILE surgery.In this column, I invite Tushya Om Parkash, MBBS, MS, and Rohit Om Parkash, MBBS, MS, to explain this sign that they have discover…
Contact lens wearer experiences persistent decreased vision, ocular pain
A 56-year-old woman with a history of relapsed/refractory IgG kappa multiple myeloma presented with a 3-day history of right eye redness, pain, photophobia and profound visual decline.She reported frequent overnight wear of daily disposable soft contac…
Rare Eye Disease Gets First NHS Drug Recommendation
NICE’s recommendation of idebenone (Raxone) for Leber hereditary optic neuropathy offers hope for patients against visual impairment. Medscape News UK
Study Counters Others on GLP-1, Diabetic Retinopathy Link
An observational study of 160,000 patients with diabetes taking GLP-1 drugs finds no heightened risk for retinopathy complications. Medscape Medical News